Use of human microsomes and deuterated substrates: an alternative approach for the identification of novel metabolites of ketamine by mass spectrometry
- PMID: 19448136
- PMCID: PMC2712439
- DOI: 10.1124/dmd.108.026328
Use of human microsomes and deuterated substrates: an alternative approach for the identification of novel metabolites of ketamine by mass spectrometry
Abstract
In vitro biosynthesis using pooled human liver microsomes was applied to help identify in vivo metabolites of ketamine by liquid chromatography (LC)-tandem mass spectrometry. Microsomal synthesis produced dehydronorketamine, seven structural isomers of hydroxynorketamine, and at least five structural isomers of hydroxyketamine. To aid identification, stable isotopes of the metabolites were also produced from tetra-deuterated isotopes of ketamine or norketamine as substrates. Five metabolites (three hydroxynorketamine and two hydroxyketamine isomers) gave chromatographically resolved components with product ion spectra indicating the presence of a phenolic group, with phenolic metabolites being further substantiated by selective liquid-liquid extraction after adjustments to the pH. Two glucuronide conjugates of hydroxynorketamine were also identified. Analysis by LC-coupled ion cyclotron resonance mass spectrometry gave unique masses in accordance with the predicted elemental composition. The metabolites, including the phenols, were subsequently confirmed to be present in urine of subjects after oral ketamine administration, as facilitated by the addition of deuterated metabolites generated from the in vitro biosynthesis. To our knowledge, phenolic metabolites of ketamine, including an intact glucuronide conjugate, are here reported for the first time. The use of biologically synthesized deuterated material as an internal chromatographic and mass spectrometric marker is a viable approach to aid in the identification of metabolites. Metabolites that have particular diagnostic value can be selected as candidates for chemical synthesis of standards.
Figures
References
-
- Adamowicz P and Kala M (2005) Urinary excretion rates of ketamine and norketaine following therapeutic ketamine administration: method and detection window consideration. J Anal Toxicol 29 376–382. - PubMed
-
- Adams JD Jr, Baillie TA, Trevor AJ, and Castagnoli N Jr (1981) Studies on the biotransformation of ketamine. 1–Identification of metabolites produced in vitro from rat liver microsomal preparations. Biomed Mass Spectrom 8 527–538. - PubMed
-
- Anari MR, Burton RW, Gopaul S, and Abbott FS (2000) Metabolic profiling of valproic acid by cDNA-expressed human cytochrome P450 enzymes using negative-ion chemical ionization gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 742 217–227. - PubMed
-
- Apollonio LG, Pianca DJ, Whittall IR, Kyd JM, and Maher WA (2006) A comparison of atmospheric pressure chemical ionization and electrospray ionization in testing for amphetamine-type substances and ketamine using ultra-performance liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 20 2777–2780. - PubMed
-
- Arnell R, Johannisson R, Lindholm J, Fornstedt T, Ersson B, Ballagi A, and Caldwell K (2007) Biotechnological approach to the synthesis of 9α-hydroxylated steroids. Prep Biochem Biotechnol 37 309–321. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
